Gastrointestinal Cancer News

Precancerous lesions that develop from HPV genotypes not included in vaccines have similar malignant potential as genotypes that are included in vaccines, according to study results.

Azathioprine did not increase the risk for cholangiocarcinoma in patients with primary sclerosing cholangitis, according to recent findings published in Clinical Gastroenterology and Hepatology.

Colorectal cancer incidence has been increasing steadily among Americans younger than 50 years, the age at which the U.S. Preventive Services Task Force recommends starting routine screening.

The National Comprehensive Cancer Network Oncology Research Program awarded grants to three investigators who are studying bavituximab as part of combination treatments for cancer.

The FDA approved the first generation of proton beam therapy nearly 30 years ago.

Aspirin and other inhibitors of COX-2 have a clear impact on multiple aspects of colorectal cancer tumorigenesis.

Earlier initiation of palliative care improved quality of life and coping abilities of patients with advanced lung and gastrointestinal cancers, according to study results presented at the Palliative Care in Oncology Symposium.

Results of a phase 1b study presented at the ASCO Annual Meeting may be “the first crack in the ceiling” in regard to the use of immunotherapy in colon cancer, according to J. Randolph Hecht, MD, of UCLA.

The national cancer moonshot initiative’s blue ribbon panel delivered 10 recommendations to form a 5-year research blueprint to accelerate progress against cancer at the NCI’s National Cancer Advisory Board meeting.

One-third of “mystery shopper” callers received limited or inaccurate information regarding palliative care services offered at NCI–designated cancer centers, according to study results presented at the Palliative Care in Oncology Symposium.